Mohammad Al Majali Profile
Mohammad Al Majali

@Mo_majali91

Followers
631
Following
284
Media
31
Statuses
401

NeuroEndovascular Surgery Fellow at SVMC |Former Vascular Neurology @IowaVascular |Former Chief Resident @slusom | 🇯🇴 🇺🇸

Joined August 2021
Don't wanna be here? Send us removal request.
Explore trending content on Musk Viewer
@Mo_majali91
Mohammad Al Majali
2 years
الحمدالله Board certified neurologist!
Tweet media one
23
0
347
@Mo_majali91
Mohammad Al Majali
1 year
سأل جلالُ الدين الرومي, شمسَ الدين التبريزي: "كيف تبردُ نار النفس؟ قال: بالاستغناء، استغنِ يا ولدي، فمن تَركَ مَلَكْ. قال جلال: وماذا عن البشر؟ قال: هم صنفان؛ من أراد منهم هَجْرَكَ وَجَدَ في ثُقْب الباب مخرجاً، ومن أراد وُدَّكَ ثَقَبَ في الصخرة مدخلا".
0
24
148
@Mo_majali91
Mohammad Al Majali
2 years
Thrilled and honored to be graduating from Saint Louis University- Department of Neurology! Cheers to my family, mentors, colleagues and everyone who helped throughout my career. It was a sweet surprise to get the "best Teaching and Research" awards! #NeuroTwitter
Tweet media one
Tweet media two
Tweet media three
Tweet media four
7
0
91
@Mo_majali91
Mohammad Al Majali
1 year
الحمدالله I'm honored to have received the Excellence in Clinical Teaching Award at the University of Iowa! It's a privilege to work alongside some of the brightest minds in the field @IowaVascular @IowaNeurology @esamaniego @ashabanmd @GhannamMalik @KoulMD @svinsociety
Tweet media one
Tweet media two
11
0
71
@Mo_majali91
Mohammad Al Majali
1 year
Wrapping up my week on Neuroendovascular call with bilateral PCA #stroke , 1 pass, #TICI3 through #radial access! Friday night cases can be the best cases!
Tweet media one
1
1
47
@Mo_majali91
Mohammad Al Majali
2 years
This kind of thing makes long days worth it. NIHSS of 20 -->1 Blessed to work with an outstanding, compassionate, and very hard-working team. @IowaVascular @esamaniego @ashabanmd @CerebrovascLab @CPDerdeyn @KoulMD @svinsociety
Tweet media one
3
4
45
@Mo_majali91
Mohammad Al Majali
3 years
With the Legendary @oozaidat who inspired me into Endovascular Neurology! Jordanians at @svinsociety 🇯🇴 🇺🇸 #النشامى
Tweet media one
4
3
41
@Mo_majali91
Mohammad Al Majali
20 days
“Two things define you: Your patience when you have nothing and your attitude when you have everything.”
0
8
41
@Mo_majali91
Mohammad Al Majali
1 year
Cheers to new beginnings! Thrilled to be joining @oozaidat and his team for my Neuroendovascular Surgery fellowship. Thank you @IowaVascular , @IowaNeurology and Saint Louis University for all the support. @svinsociety @SNISinfo #MedTwitter #Neurotwitter
Tweet media one
3
0
39
@Mo_majali91
Mohammad Al Majali
2 years
A great grand round by Dr @AshuPJadhav on "Challenges and Opportunities in Interventional Neurology!" Thank you for joining us today! @slusom @svinsociety
Tweet media one
0
7
34
@Mo_majali91
Mohammad Al Majali
7 months
Excited to share our work on the safety of thrombolytics in patients on DOACs. Largest sample size in the literature. Great effort by my friend and partner @GhannamMalik If interested, please join @DOIT_trial @ShadiYaghi2
3
9
33
@Mo_majali91
Mohammad Al Majali
1 year
واعلم يا فتى، أنّه في أحايين كثيرة، يكون المقصود من الخسارة تغيير الطريق.. بدءاً باليأس منه، ثمّ إعادة النظر فيه.. فالنظر إلى غيره.. ثم السير إلى هناك!
1
1
29
@Mo_majali91
Mohammad Al Majali
7 days
⚠️ ⚠️ 📢 Fellowship application for NeuroEndovascular Surgery with the master Dr Zaidat ( @oozaidat ) is open for July 1, 2025. Please feel free to reach out. oozaidat @mercy .com Malmajali @mercy .com Good luck! @svinsociety @SNISinfo @StrokeAHA_ASA
0
4
30
@Mo_majali91
Mohammad Al Majali
3 years
Presenting our work at @svinsociety Great talks, cutting edge technology and top-notch endovascular surgeons. Excited to be part of this! #SVINAM #SVIN2021 @SVINJournal
Tweet media one
5
1
29
@Mo_majali91
Mohammad Al Majali
3 months
Hot off the press! Does the Ischemic Core Really Matter? An Updated Systematic Review and Meta‐Analysis of Large Core Trials After TESLA, TENSION, and LASTE | Stroke: Vascular and Interventional Neurology @StrokeAHA_ASA @SVINJournal @svinsociety
Tweet media one
4
8
29
@Mo_majali91
Mohammad Al Majali
2 years
Tweet media one
0
4
28
@Mo_majali91
Mohammad Al Majali
2 years
A great endovascular hands-on session on mechanical thrombectomy and aneurysms coiling at SLU! Thanks to our amazing endovascular attendings and fellows for teaching our residents. @slusom @svinsociety #neurotwitter #stryker
Tweet media one
Tweet media two
Tweet media three
3
0
26
@Mo_majali91
Mohammad Al Majali
3 years
Congratulations brother on becoming @svinsociety board member! Great things yet to happen! @elghanemmoh #SVINAM #SVIN2021
Tweet media one
2
0
25
@Mo_majali91
Mohammad Al Majali
1 year
Proud to be part of this landmark study! Thank you @IowaVascular @esamaniego @CerebrovascLab for this opportunity
@NEJM
NEJM
1 year
Presented at #ISC23 : In the SELECT2 trial involving patients with large acute strokes, endovascular thrombectomy resulted in better functional outcomes than medical care alone but was associated with vascular complications.
Tweet media one
3
178
330
0
1
24
@Mo_majali91
Mohammad Al Majali
2 years
The late night code strokes and cases make celebrating our colleague’s @KoulMD birthday worth it. Blessed to work with a phenomenal group of Vascular and Interventional Neurologists ! @esamaniego @GhannamMalik @ashabanmd @IowaVascular @CerebrovascLab
Tweet media one
1
1
23
@Mo_majali91
Mohammad Al Majali
2 years
Excited to be part of this initiative led by the Jordanian American Physicians Academy in collaboration with the Local Health System Sustainability Project -LHSS funded by USAID. #GlobalNeurology #curingcoma @neurocritical
Tweet media one
1
2
23
@Mo_majali91
Mohammad Al Majali
1 year
My little brother has been killing it lately! I have seen how hard he's worked over the years, and it's really inspiring. Congratulations @slusom 🐐 #IMG #surgery #MedTwitter #ProudMoment
Tweet media one
Tweet media two
Tweet media three
0
0
22
@Mo_majali91
Mohammad Al Majali
5 months
Predictors of Good Functional Outcomes in Posterior Circulation Stroke After Mechanical Thrombectomy With Stent Retrievers: An Individual Patient‐Data Pooled Analysis From the TRACK and NASA Registries led by our superstar resident @AshouriYazan
2
3
18
@Mo_majali91
Mohammad Al Majali
1 year
After an exciting and productive stretch on stroke & NICU with the Dream team! #EidMubarak #workhardplayharder #21days @IowaVascular @esamaniego @IowaNeurology
Tweet media one
2
0
19
@Mo_majali91
Mohammad Al Majali
1 year
Tweet media one
Tweet media two
0
4
18
@Mo_majali91
Mohammad Al Majali
2 years
Tweet media one
Tweet media two
0
4
16
@Mo_majali91
Mohammad Al Majali
2 years
Standing on the shoulders of giants! #TheFourHorsemenOfNeuerology
@KoulMD
Prateeka Koul
2 years
What an amazing time learning from stroke and endovascular cases from @Mo_majali91 and Sahs grand rounds lecture from @CPDerdeyn @IowaVascular 📸 @Mo_majali91 & myself @KoulMD
Tweet media one
0
0
6
1
1
16
@Mo_majali91
Mohammad Al Majali
2 years
Strong presence of @IowaVascular at #SVINAM2022 Extremely honored and privileged to be part of this amazing and humble group of scientists and stroke leaders. @GhannamMalik @KoulMD @esamaniego @CerebrovascLab @ssanchezneuro @mili_galecio
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
3
14
@Mo_majali91
Mohammad Al Majali
1 year
In rodent models, intravenous URIC ACID exceed its prespecified efficacy boundary! Proud of @IowaVascular @esamaniego @GhannamMalik @KoulMD @CerebrovascLab @ashabanmd @CPDerdeyn #Neuroprotection
Tweet media one
Tweet media two
0
3
13
@Mo_majali91
Mohammad Al Majali
2 years
@KoulMD
Prateeka Koul
2 years
@Mo_majali91 and I got to try our hands at mechanical thrombectomy in this flow model - TICI3! Thank you @IowaVascular @esamaniego for the opportunity!
Tweet media one
Tweet media two
Tweet media three
0
2
7
0
2
14
@Mo_majali91
Mohammad Al Majali
2 years
@CerebrovascLab
Cerebrovascular & Neurointerventional Lab
2 years
#Challengeaccepted here in Iowa we have #NoMercy on stroke. Push-up challenge, for each stroke that happens every 40 seconds! Challenge to @AshuPJadhav @SunilAShethMD @TudorGJovin @AlexandraCzap @svinsociety @SVIN_MT2020
2
19
65
0
5
14
@Mo_majali91
Mohammad Al Majali
3 months
Congratulations, brother! 🎊 Carotid stenting beats CEA, hands down!! 🫡🤣 #CEA #CAS #vascularsurgery #Neuroendovascular
@SLUVascular
Saint Louis University Vascular Surgery
3 months
Thrilled to have matched one of our @SLUGenSurg residents into our vascular fellowship! #VascularFellowMatch24
Tweet media one
0
0
21
0
0
14
@Mo_majali91
Mohammad Al Majali
2 years
Be well! Enjoy life, eat healthy and workout! Always Fight Stroke @IowaVascular #SVINWellness #CrossFit #NoStrokeLeftBehind
Tweet media one
0
1
13
@Mo_majali91
Mohammad Al Majali
3 months
Hot off the press! In the multicenter TARGET Registry, 75.8% of aneurysms achieved mid-term complete occlusion,and 96% achieved complete/near complete occlusion with excellent independent functional outcome @AshouriYazan @oozaidat @svinsociety @SNISinfo
0
0
13
@Mo_majali91
Mohammad Al Majali
10 months
Check out our paper! Stentplasty with the Tigertriever
@JNIS_BMJ
JNIS
10 months
Stentplasty with the Tigertriever! The answer to acutely occluded ICAD? Check out this new paper What sets this device apart is its operator-controlled stent expansion—a potential game-changer in ICAD management! @DanniDiestro @ducruetaf @DrAltschul
Tweet media one
0
14
27
0
1
13
@Mo_majali91
Mohammad Al Majali
2 years
It almost came to an end! 4 more weeks! #neurotwitter #graduation @slusom
Tweet media one
1
0
11
@Mo_majali91
Mohammad Al Majali
2 months
❤️
Tweet media one
0
0
10
@Mo_majali91
Mohammad Al Majali
9 months
Many necessary imaging studies are canceled because of fear the contrast dye may hurt the kidneys. Using high doses of Lipitor (80 mg) for 3 days prior to the study may protect the kidneys from contrast dye damage. Use it as a preventative strategy. #FunFact
1
3
10
@Mo_majali91
Mohammad Al Majali
8 months
Improving the IMG Resident to Faculty Pipeline: Why and How @CPDerdeyn
0
1
10
@Mo_majali91
Mohammad Al Majali
6 months
Thrilled to be part of this terrific work led by an amazing and great colleague @ShadiYaghi2 ! Congratulations @StrokeAHA_ASA @GhannamMalik #ISC24
@StrokeAHA_ASA
Stroke AHA/ASA
6 months
🧵 #ISC24 Results from the multi-center STOP-CAD study: Exploring cervical artery dissection #CAD treatments, anticoagulation vs. antiplatelet therapy reveals a trend toward lower ischemic stroke risk with anticoagulation, mainly in those with occlusive disease.
Tweet media one
1
71
136
0
2
10
@Mo_majali91
Mohammad Al Majali
1 year
Proud of such a great team!
@IowaVascular
Iowa Vascular
1 year
Tweet media one
1
1
17
0
0
9
@Mo_majali91
Mohammad Al Majali
2 months
Elevated thyroid autoantibodies were frequently observed in patients with MMD (MoyaMoya disease). The results of the present study suggest that immune aberrancies associated with or underlying thyroid autoimmunity are also playing a role in developing MMD.
0
0
9
@Mo_majali91
Mohammad Al Majali
2 years
It was a great pleasure having @CPDerdeyn today for our grand round! A nice review on treatment options for subacute and chronic carotid occlusion. @slusom @StrokeAHA_ASA @SNISinfo @IowaVascular
Tweet media one
0
1
9
@Mo_majali91
Mohammad Al Majali
1 year
Great update by the brightest minds in the field, and I'm privileged to be trained under one of them @CPDerdeyn
@BrianHoh1
Brian Hoh, MD, MBA
1 year
Hot off the press! @AHAScience @American_Heart @American_Stroke Subarachnoid Hemorrhage Guidelines published today in @StrokeAHA_ASA . Clinicians who see patients with SAH will need to read this update to the previous 2012 guidelines:
Tweet media one
3
100
321
0
3
7
@Mo_majali91
Mohammad Al Majali
2 years
Very well deserved @esamaniego
@BAFOUND
Brain Aneurysm Foundation
2 years
Meet Dr. Edgar A Samaniego from the University of Iowa, who is the recipient of the Renee Joyce Chair of Research. To read more about Edgar, click here, #ResearchGrant #1in50 #BAF #ResearchMatters
1
3
32
0
1
7
@Mo_majali91
Mohammad Al Majali
1 year
Tweet media one
1
1
7
@Mo_majali91
Mohammad Al Majali
5 months
Hot off the press! Check out our latest publication, led by the talented @Qudahmd
1
0
7
@Mo_majali91
Mohammad Al Majali
2 years
We are thrilled to have these bright physicians as part of our SLU Neurology program! Welcome aboard! #NMatch2022 @slusom
Tweet media one
0
1
7
@Mo_majali91
Mohammad Al Majali
2 years
Great initiative by @ShadiYaghi2 and excited to part of it @IowaVascular @esamaniego @GhannamMalik
@ShadiYaghi2
Shadi Yaghi
2 years
The STOP-CAD study comparing dual antiplatelet therapy to oral anticoagulation in cervical artery dissection has reached the 1250 patient milestone. Grateful for all the contributing sites & looking forward to completing the study in the next few months. #stroke #dissection 🛑CAD
Tweet media one
8
19
143
0
0
7
@Mo_majali91
Mohammad Al Majali
6 days
Check out our review on large core thrombectomy!
@NYNeuroendovasc
FAM Neuroscience Research & Innovation Lab
7 days
Spot on analysis-Does the Ischemic Core Really Matter? An Updated Systematic Review and Meta‐Analysis of Large Core Trials After TESLA, TENSION, and LASTE | @SVINJournal @CerebrovascLab @Mo_majali91 @amrsarrajMD @almuftifawaz @TudorGJovin @NguyenThanhMD
0
3
10
0
0
6
@Mo_majali91
Mohammad Al Majali
6 months
Solid work, boss @oozaidat Congratulations 🎊
@Qudahmd
Abdullah Al-Qudah
6 months
Dr.Osama Zaidat @oozaidat presenting One-Year Outcome for TESLA #ISC24
Tweet media one
0
1
9
0
0
6
@Mo_majali91
Mohammad Al Majali
3 months
The most common clinical outcome post-VSS in IIH patients is initial symptomatic improvement followed by symptom recurrence in about 60% at a mean of 274 days, despite a consistent intracranial pressure reduction.
0
1
6
@Mo_majali91
Mohammad Al Majali
1 year
My thoughts and prayers with the people of Syria and Türkiye! اللهم احفظ البشرية جمعاء
@AANmember
American Academy of Neurology
1 year
A Message from AAN President @OrlyA : Our AAN Members in Türkiye and Syria #Neurology #NeuroTwitter
Tweet media one
2
10
22
0
0
5
@Mo_majali91
Mohammad Al Majali
1 year
Congratulations @oozaidat outstanding work as always
@TudorGJovin
Tudor G. Jovin, MD
1 year
Congrats to Albert Yoo, @oozaidat and TESLA investigators. Strong trends towards efficacy of EVT in large core pts (median ASPECTS 4), despite only 25% pts treated in 0-6 hr window. Results totally in line with the 3 published large core trials. Awaiting TENSION & LASTE results !
Tweet media one
0
41
129
0
1
5
@Mo_majali91
Mohammad Al Majali
1 year
Strong work @ShadiYaghi2 It's great to be part of STOP-CAD @IowaVascular @GhannamMalik @esamaniego
@ShadiYaghi2
Shadi Yaghi
1 year
STOP-CAD is winding down. We are up to ~4500 patients. I’m extremely grateful for the support & effort from all contributing sites. We have started data cleaning & hoping to submit our results to #ISC24 Which treatment wins: DAPT, OAC, or aspirin? Stay tuned!
Tweet media one
7
12
132
0
2
5
@Mo_majali91
Mohammad Al Majali
6 months
Thank you @Lance_Tran_ and @StrokeAHA_ASA for highlighting our work!
@StrokeAHA_ASA
Stroke AHA/ASA
6 months
Commentary: “Transcarotid Arterial Revascularization of Symptomatic Internal Carotid Artery Disease: A Systematic Review and Study-Level Meta-Analysis” In this new #BloggingStroke post, @Lance_Tran_ discusses #Stroke article by @GhannamMalik et al, presented this week at #ISC24 .
Tweet media one
1
6
15
0
2
5
@Mo_majali91
Mohammad Al Majali
1 year
🇸🇾 🇹🇷 #TurkeyQuake #Syria
Tweet media one
0
2
4
@Mo_majali91
Mohammad Al Majali
1 year
With growing indications for theombolytics and MT, there is still a shortage of specialists! Are neurologists interested in filling the gap? @svinsociety @StrokeAHA_ASA #burnout
@JNIS_BMJ
JNIS
1 year
Is #stroke call getting harder? YES!! Kwok et al found #thrombectomy rates went up 65% in the 2 years after time window out to 24 hours. Read this article and ask your boss/hospital for more resources for the team! #burnout #neurology @alex_spiotta
Tweet media one
1
13
35
1
2
4
@Mo_majali91
Mohammad Al Majali
1 year
@ashabanmd Better assessment for disability! I would rely more on a thorough neurological exam (including gait assessment) rather than pure NIHSS evaluation.
2
0
4
@Mo_majali91
Mohammad Al Majali
1 year
Always remember Clinical Trials ≠ Clinical Practice! Great summary by @MohtadyNababteh
@MohtadyNababteh
Muhtadi Alnababteh
1 year
How prevalent is publication bias? Turner et al examined all completed antidepressant trials registered with the FDA (n=74) resorting to the Freedom of Information Act to obtain the complete data, as 1/3 of studies remained unpublished.
2
0
6
0
0
2
@Mo_majali91
Mohammad Al Majali
3 months
It is possible that this subset of patients (as opposed to those whose headaches are related to other mechanisms) would be more likely to demonstrate a favorable response to superselective lidocaine infusion into the MMAs.
0
0
3
@Mo_majali91
Mohammad Al Majali
2 years
Looking forward to working with you!
0
0
3
@Mo_majali91
Mohammad Al Majali
2 years
@DrAdamBat And 45%-55% of the time, it is reversible!
0
0
3
@Mo_majali91
Mohammad Al Majali
3 years
Excited to be part of this outstanding work! Applied forecasting for delayed cerebral ischemia prediction post subarachnoid hemorrhage: Methodological fallacies @NabihaQuadri @NeurosurgerySlu @svinsociety @SNISinfo @StrokeAHA_ASA #NoStrokeLeftBehind
0
2
3
@Mo_majali91
Mohammad Al Majali
9 months
Interesting debate @CPDerdeyn
@JNIS_BMJ
JNIS
9 months
Debate on stenting for idiopathic intracranial hypertension! @DrMichaelLevitt and @CPDerdeyn make their points: & Should venous stenting be 1st line tx or are RCTs needed? Comment below! Image from
Tweet media one
1
15
48
0
0
3
@Mo_majali91
Mohammad Al Majali
4 months
Interesting read!
0
0
2
@Mo_majali91
Mohammad Al Majali
2 years
Congratulations @CerebrovascLab and @IowaVascular Very well deserved @mili_galecio
@CerebrovascLab
Cerebrovascular & Neurointerventional Lab
2 years
Congratulations to the team! Dr. Ortega receiving the 2022 Distinguished service award and Milagros receiving the pilot grant. Looking forward to the upcoming months! @svinsociety @SunilAShethMD @AmeerEHassan @mili_galecio
Tweet media one
Tweet media two
Tweet media three
Tweet media four
2
6
34
0
0
2
@Mo_majali91
Mohammad Al Majali
2 years
0
0
2
@Mo_majali91
Mohammad Al Majali
2 years
Excited to be part of your success! Cannot be more proud of you brother. Welcome aboard @Match2022_bot @AANMember
@zaiddnajdawi
Zaid Najdawi
2 years
@gharaibeh_a Before knowing where I matched on Friday, I would like to thank everyone who helped and guided me, my medical school, my mentors and colleagues, and everyone in the neurology field. @MSAladawi @ShaerQasem @SitaraKoneru @SherriBraksick @Mo_majali91 @MohamedElfilMD @ElieNaddaf3
3
0
13
0
0
2
@Mo_majali91
Mohammad Al Majali
10 months
@CPDerdeyn @bpoliceni @IowaRAD Good luck, Dr. Derdeyn! You have been a great mentor. Wish you all the best in Virginia.
0
0
2
@Mo_majali91
Mohammad Al Majali
1 year
Thank you for your warm and kind wishes
1
0
2
@Mo_majali91
Mohammad Al Majali
2 years
@KoulMD
Prateeka Koul
2 years
0
0
0
0
0
2
@Mo_majali91
Mohammad Al Majali
3 years
SLUSOM medical students have selected my brother Fawaz H. Al-Majali and myself to be amongst the outstanding clinical educators in General Surgery and Neurology for the past year. #countyourblessings #Neurology #surgery
Tweet media one
Tweet media two
Tweet media three
0
0
2
@Mo_majali91
Mohammad Al Majali
11 months
100%
@TudorGJovin
Tudor G. Jovin, MD
11 months
Yesterday, on a flight from Europe to US, responding to a medical emergency, I placed an iv in an 88 yr old. An EMT co-passenger asked: "you are a neurologist; how come you can place an iv?" My reply: "times have changed buddy. Neurologists are increasingly intervention oriented"
12
15
233
0
0
2
@Mo_majali91
Mohammad Al Majali
1 year
Very well said 👏
@EladLevyMD
Elad Levy
1 year
@ErikaPetersenMD @EKNduom This publications arms race starts from the top. We wrongly promote academic careers on numbers of pubs and grants, not service/med-ed / or quality initiatives. The trickle-down effect is inevitable. I promote people, not resumes. @UB_Neurosurgery @Jacobs_Med_UB
2
5
68
0
0
2
@Mo_majali91
Mohammad Al Majali
2 months
Solid work, boss @oozaidat
@GalaxyThera
Galaxy Therapeutics
2 months
Galaxy Therapeutics has made it across the Pacific! We are honored to have our first case in Australasia region performed by Dr. James Caldwell at Auckland City Hospital. A great case with a great outcome. We look forward to treating many more patients in NZ/Australia. @oozaidat
Tweet media one
1
4
18
0
0
2
@Mo_majali91
Mohammad Al Majali
11 months
Promising data in the pipeline! @oozaidat
@JNIS_BMJ
JNIS
11 months
Latest content: Zoppo et al. used a rabbit model to test SEAL Arc, a novel new double layered, neck bridging, hybrid nitinol mesh intrasaccular device and compare to the WEB device with excellent complete early aneurysm occlusion. #aneurysm #flowdiversion
Tweet media one
1
18
51
0
0
2
@Mo_majali91
Mohammad Al Majali
2 years
@TareqAlsoudi Thank you Hakeem! You are truly missed
0
0
1